Literature DB >> 25213047

Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma.

Allan T Luskin1, Bradley E Chipps2, Lawrence Rasouliyan3, Dave P Miller3, Tmirah Haselkorn4, Alejandro Dorenbaum5.   

Abstract

BACKGROUND: Few data are available that evaluate the relationship among asthma exacerbations, asthma triggers, and asthma-related quality of life (QoL).
OBJECTIVE: To evaluate the impact of asthma exacerbations and asthma triggers on QoL.
METHODS: Patients with severe or difficult-to-treat asthma, ages ≥ 13 years (n = 2679) from the TENOR (The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens) 3-year observational study were included. Exacerbations were defined hierarchically in descending order of severity (hospitalization, emergency department [ED] visit, steroid burst, no exacerbation) by using data from months 6 and 12. The total number (frequency) of exacerbations was assessed. Asthma-related QoL was measured at month 12 by using the Mini-Asthma QoL Questionnaire (Mini-AQLQ); self-reported asthma triggers were collected at baseline and annually. We used 1-way ANOVA to test for differences in Mini-AQLQ domain scores across asthma exacerbation severity, the total number of asthma exacerbations, and the number of asthma triggers.
RESULTS: A significant decrease (P < .001) in Mini-AQLQ domain scores was seen with increasing severity of asthma exacerbation (no exacerbation, steroid burst, ED visit, and hospitalization); symptom (5.5, 4.8, 4.3, and 4.2), activity (5.8, 5.2, 4.6, and 4.4), emotional (5.6, 5.0, 4.4, and 4.2), exposure (5.0, 4.5, 4.0, and 3.9); and overall (5.5, 4.9, 4.3, and 4.1). Increasing exacerbation frequency and the number of baseline asthma triggers also were associated with significant decreases in Mini-AQLQ domain scores. An increasing number of asthma triggers were associated with an increase in severity and frequency of exacerbations.
CONCLUSION: Avoidance of asthma triggers may reduce exacerbation rates and improve asthma-related QoL in patients with severe or difficult-to-treat asthma. Interventional studies are warranted to further explore these outcomes.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergic triggers; Difficult-to-treat asthma; Quality-of-life; Severe asthma

Mesh:

Year:  2014        PMID: 25213047     DOI: 10.1016/j.jaip.2014.02.011

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  17 in total

1.  High Use of Antidepressant Medication in Both Mild-to-Modelate and Possible Severe Asthma - A Nationwide Cohort Study.

Authors:  Kjell Erik Julius Håkansson; Martino Renzi-Lomholt; Vibeke Backer; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2022-01-05

2.  The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results.

Authors:  Christopher S Ambrose; Bradley E Chipps; Wendy C Moore; Weily Soong; Jennifer Trevor; Dennis K Ledford; Warner W Carr; Njira Lugogo; Frank Trudo; Trung N Tran; Reynold A Panettieri
Journal:  Pragmat Obs Res       Date:  2020-07-16

3.  A Review of the CD4+ T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population.

Authors:  Ravi S Misra
Journal:  EC Microbiol       Date:  2014

4.  A territory-wide study on the factors associated with recurrent asthma exacerbations requiring hospitalization in Hong Kong.

Authors:  Ka Pang Chan; Fanny Wai San Ko; Kwun Cheung Ling; Pik Shan Cheung; Lee Veronica Chan; Yu Hong Chan; Yi Tat Lo; Chun Kong Ng; Macy Mei-Sze Lui; Kwok Sang Wilson Yee; Cee Zhung Steven Tseng; Pak Yiu Tse; Mo Lin Maureen Wong; Kah Lin Choo; Wai Kei Lam; Chun Man Wong; Sheng Sheng Ho; Chung Tat Lun; Christopher Kei Wai Lai
Journal:  Immun Inflamm Dis       Date:  2021-03-03

Review 5.  The Danish National Database for Asthma: establishing clinical quality indicators.

Authors:  Susanne Hansen; Benjamin Hoffmann-Petersen; Asger Sverrild; Elvira V Bräuner; Jesper Lykkegaard; Uffe Bodtger; Lone Agertoft; Lene Korshøj; Vibeke Backer
Journal:  Eur Clin Respir J       Date:  2016-11-08

6.  Prevalence and Geographic Distribution Pattern of Asthma in Tehran by ECRHS.

Authors:  Hooman Sharifi; Mostafa Ghanei; Makan Sadr; Habib Emami; Atefeh Fakharian; Zahra Hessami; Mahshid Aryanpur; Hamidreza Jamaati; Mohammad Reza Masjedi
Journal:  Tanaffos       Date:  2016

Review 7.  Asthma referrals: a key component of asthma management that needs to be addressed.

Authors:  David Price; Leif Bjermer; David A Bergin; Rafael Martinez
Journal:  J Asthma Allergy       Date:  2017-07-25

8.  Anti-IL-5 therapy in patients with severe eosinophilic asthma - clinical efficacy and possible criteria for treatment response.

Authors:  Nora Drick; Benjamin Seeliger; Tobias Welte; Jan Fuge; Hendrik Suhling
Journal:  BMC Pulm Med       Date:  2018-07-18       Impact factor: 3.317

Review 9.  Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma - a systematic review and meta-analysis.

Authors:  Daniel P Henriksen; Uffe Bodtger; Kirsten Sidenius; Niels Maltbaek; Lars Pedersen; Hanne Madsen; Ehm A Andersson; Ole Norgaard; Louise Klokker Madsen; Bo L Chawes
Journal:  Eur Clin Respir J       Date:  2018-11-07

Review 10.  Severe asthma and quality of life.

Authors:  Elham Hossny; Luis Caraballo; Thomas Casale; Yehia El-Gamal; Lanny Rosenwasser
Journal:  World Allergy Organ J       Date:  2017-08-21       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.